In this ongoing series, Dr. Paul Auwaerter from Johns Hopkins School of Medicine provides a weekly update on COVID-19 and answers your questions. In this episode, he discusses the latest clinical data and answers your questions on topics such as therapeutics, chest X-rays and CTs, immunocompromised patients, & antibody and viral oropharyngeal testing.
Join us in a follow up to last week’s webcast – COVID-19: Keeping Up with a Moving Target and the first of our new coronavirus educational activities as part of DKBmed’s Radio Hour. Today Dr. Auwaerter provides us with updates on infection rates, therapeutics, and testing. Plus, he answers your questions about topics such as proper protective equipment, use of ibuprofen with COVID-19, and pregnancy.
COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Dr. Paul Auwaerter from Johns Hopkins School of Medicine covers what we know about the coronavirus outbreak in this podcast. Visit https://covid19.dkbmed.com/ for ongoing updates on COVID-19 from trusted medical professionals.
Volume 4, Issue 8.
In this podcast guest author Steven Rowe, MD, Associate Professor of Medicine from the University of Alabama at Birmingham, describes how CFTR modulator therapy fits into the clinical armamentarium of CF lung disease; identifies which patients are most appropriate for CF modulator treatment; and describes current research efforts and how to identify patients suitable for referral for consideration in CFTR modulator clinical trials.
Volume 4, Issue 6.
In this podcast guest author Dr. Margaret Rosenfeld from the University of Washington School of Medicine, discusses the rationale for early Pseudomonas aeruginosa eradication, Identifies the inhaled and oral antibiotics that have been compared in clinical trials for early Pseudomonas eradication, and describes the potential adverse effects of early Pseudomonas eradication therapy.
Volume 4, Issue 4.
In this podcast guest author Amanda Radmer Leonard, Pediatric Nutrition Practitioner, of the Johns Hopkins Children’s Center, describes approaches to the treatment of low vitamin D levels in patients with cystic ﬁbrosis, discuss the variability of fecal elastase result during the ﬁrst year of life, and summarizes the importance of tailoring nutritional interventions to speciﬁc patient and family situations.
Volume 4, Issue 2.
Nonadherence to any medical regimen is common particularly among adolescents and young adults, and cystic fibrosis (CF) is no exception. There are many barriers to following the complex daily regimen that CF management requires, and researchers and clinicians have not yet found the ideal approach for counseling and supporting patients to improve and maintain their level of adherence. In this podcast Dr. Kristin Riekert, of The Johns Hopkins Adherence Research Center discusses best practices for determining which clinic patients are nonadherent and Identifies risk factors for nonadherence.